The Q4-2023 CBFO results show the company's potential to reach cash flow breakeven. Management is confident that with high variable margins from product sales, closing the remaining gap is achievable. Precipio's CEO, Ilan Danieli, is optimistic about the company's financial independence and growth potential.
$Precipio(PRPO.US)$I grabbed this stock after it pumped, then dipped to 2.8. I don't think it is going any lower than 2.8 again or I can always buy more. I don't want to miss out on this stock pumping though. It has been waiting to head up to the 7$ PT that analysts have for it.
Precipio股票討論區
NEWS
Precipio Secures a short-term $500K Credit Facility
@OBIfromMEM
$Eargo(EAR.US)$ holding enter 1.16
strong watch list
$Second Sight Medical Products(EYES.US)$
$Chembio Diagnostics(CEMI.US)$
$Precipio(PRPO.US)$
$36氪(KRKR.US)$
暫無評論